Join us

Our vision

Our goal is to harness the company’s breadth of scientific capabilities, team expertise and our portfolio to get a wide range of new therapies to the clinic for patient benefit.

The increase in the global radiopharmaceutical sector is expected to be dominated by theranostic developments which now have found widespread acceptance by the major global pharmaceutical companies and are the main focus of development pathways in this sector.

We seek investors and collaborations/partnerships to join us in delivering innovative new medicines to make patients live longer, disease free.